(WO201762202) A system and method for creating three-dimensional nanostructures is disclosed. The system includes a substrate bonded to a carrier using a bonding agent. The bonding agent may be vaporizable or sublimable. The carrier may be a glass or glass-like substance. In some embodiments, the carrier may be permeable having one or a plurality of pores through which the bonding agent may escape when converted to a gaseous state with heat, pressure, light or other methods. A substrate is bonded to the carrier using the bonding agent. The substrate is then processed to form a membrane. This processing may include grinding, polishing, etching, patterning, or other steps. The processed membrane is then aligned and affixed to a receiving substrate, or a previously deposited membrane. Once properly attached, the bonding agent is then heated, depressurized or otherwise caused to sublimate or vaporize, thereby releasing the processed membrane from the carrier.
(WO201762198) A prosthetic heart valve provided herein can include a cultured cell tissue leaflet. In some cases, a prosthetic heart valve can include a plurality of leaflets secured together and retained within the expandable tubular member. The cultured cell tissue can be obtained by culturing fibroblast cells, smooth muscle cells, or a combination thereof to form a sheet of cultured cells and chemically cross-linking the fibroblast cells while under tension. In some cases, the cultured cell tissue can be radially tensioned. In some cases, the cultured cell tissue can be bi-axially tensioned.
(WO201761309) A chlorine-resistant dyed fabric which is a fabric dyed by a yellow disperse dye and a blue disperse dye and/or a red disperse dye, and wherein: a main component of the yellow disperse dye is a compound represented by formula (1) or formula (2); a main component of the blue disperse dye is a compound represented by formula (3); and a main component of the red disperse dye is a compound represented by formula (4).
(JP2017060944) PROBLEM TO BE SOLVED: To provide a catalyst for selective catalytic reduction (SCR) of nitrogen oxide in gas having catalytic activity at a low temperature, high in selectivity to nitrogen, less in NO formation, good in thermal durability, and high in tolerance to carbohydrate suppression.SOLUTION: There is provided a catalyst for selective catalytic reduction (SCR) of nitrogen oxide in gas, contacts nitrogen oxide in the gas with a nitrogen-based reductant to convert it to nitrogen and is a zeolite catalyst containing at least one kind of transition metal, wherein the zeolite is small porous zeolite containing maximum ring size by 8 tetrahedral atoms, contains aluminosilicate zeolite having at least one skeleton selected from AFX and AFT and the at least one kind of transition metal contains copper and/or iron.SELECTED DRAWING: None
(WO201758822) A method of treating a human having a condition or disease related to a bone defect characterized by at least one of: increased level of an alkaline phosphatase ligand, particularly PPi, PLP, or PEA; and decreased alkaline phosphatase activity, compared to a human without said condition or disease, comprising administering to the human a therapeutically effective amount of a polypeptide comprising the amino acid sequence of SEQ ID NO: 1, wherein the polypeptide is administered through at least one subcutaneous injection to the human in a frequency of fewer than three times each week.
(WO201758780) The present disclosure describes combination therapies useful for the treatment of cancer. In particular, the invention relates to a combination therapy which comprises a PD-1 axis binding antagonist and an ALK inhibitor for treating cancer.
(WO201758757) Uses of acyl-homoserine lactone compounds are described. In particular, uses of acyl-homoserine lactone compounds as anti-thrombotic agents, to inhibit platelets from becoming hypersensitive, and/or to prevent thrombosis, are described.
(WO201757341) A powder for conductive material according to an embodiment of the present invention is composed of a large number of particles containing copper as a main component and has an average primary particle diameter of 1-200 nm, wherein the particles contain titanium on the surface or inside thereof, and the content of titanium is 0.003-0.5 atomic%.